GDF15 and metabolic dysfunction-associated steatotic liver disease: For the first time it is shown that total serum GDF15 levels are significantly increased in MASLD patients during OGTT and remain significantly higher compared to otherwise healthy individuals, pointing to a role for GDF15 as a mitokine with important roles in the pathophysiology and possibly therapeutics of MASLD.